ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
PRESS RELEASE Within the context of Sarantis Group’s strategic development, and with the aim to significantly reinforce the dynamics of the Group’s Health & Care division, the Group is including the French Company OENOBIOL in its product portfolio.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
PRESS RELEASE Main Points Sarantis Group’s turnover increased by 13.16% to €173.96 mil. from €153.73 mil. in 9m 2006. Gross profit margin increased to 50.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
PRESS RELEASE Gr. Sarantis SA will release the 9M 2007 consolidated financial results, according to the following schedule: Monday the 19th of November after ASE close – Results Release, which will be available in the Athens Stock Exchange web page (www.
Want to learn more about the Group?
Explore our latest news regarding our brands, our activities, our people and our sustainability actions!
SARANTIS Group
26, Amaroussiou - Halandriou Street
151 25 Maroussi, Athens, Greece
Tel: +30 210 6173000
Fax: +30 210 6197081
e-mail: group-info@sarantisgroup.com